Recent data from the Hong Kong Stock Exchange indicates that on February 16, JPMorgan acquired an additional 347,233 shares of SINOPHARM (01099) at an average price of HK$21.4135 per share. The total transaction value amounted to approximately HK$7.4355 million.

Following this purchase, JPMorgan's total shareholding in SINOPHARM has reached around 67.1203 million shares, representing a 5% stake in the company.